Thanks to so many who supported me. Especially to my family who made it to their first
#kidneywk
@ssfarouk
who nominated me and is my educational partner and friend.
all of my co signers, current and past
@DukeKidney
fellows, faculty, and everyone around the world
Thank you
so excited to welcome the first class of fellows in which I am full program director.
It is a surreal moment. Still recall day 1 for me in 2007 coming from
@UAMSintmedicine
Never would have imagined this day would have happened when I was sitting in the orientation room!
Very honored to be mentioned as a βOutstanding Mentorβ at
@dukemedicine
feeling very much out of place sitting next to so many people I admire
The succulent (my take)-often the most challenging mentoring comes at times/with people you least recognize/predict
Take time to listen
And the award π₯ for best title in an academic journal goes to.........
π₯ π₯
@ssfarouk
and
@ThepHunClub
For
βThe Many Faces of Calcineurin Inhibitor ToxicityβWhat the FK?β
Proud to announce my new 6 part podcast series on Chronic Kidney Disease on
@Medscape
InDiscussion
Episode 1 is with
@brendonneuen
Chronic Kidney Disease and SGLT2 Inhibitors: Usage, Monitoring, and Possible Side Effects
#Flozinate
we are happy to announce the '23
@NSMCInternship
class
Read about this group representing 11 countries
#NephForward
Thanks to the NSMC team and
@nephromythri
for helping coordinate this effort and looking forward to getting to know and mentor this group
wow.... just having a hard time comprehending that 10 year of
#NephMadness
is real. This cover of
@ajkdonline
brings back so many amazing memories. thanks to SO MANY people through the years that made this happen. Very proud of this and the support of AJKD and
@NKF
one of the things I actually do remember from med school is this...
"never treat a side effect of a medication with another medication"
Not sure why that always stuck with me
#NephJC
#Minimalist
"When my mother, Shyamala Gopalan Harris, emigrated from India at 19, she couldn't have imagined this day. Thank you Joe Biden for having the audacity to pick a woman as vice president."
-Vice President-elect Kamala Harris
Our SGLT2 inhibitor magnesium manifesto is out!
#NephFellow
Dr Robbins and Dr Chitan Shah
@UFNephrology
in
@KidneyMed
Role of Sodium-Glucose Cotransporter-2 Inhibitors in Management of Refractory Hypomagnesemia Without Overt Urinary Magnesium Wasting
Hypercalcemia β‘οΈ CHIMPANZEES π
Calcium supplementation
Hyperparathyroidism
Iatrogenic disorders (thiazides, lithium) or immobilization
Milk-alkali syndrome or multiple myeloma
Paget disease of bone
Adrenal insuf
Neoplasia
Zollinger-Ellison
Excess vit A
Excess vit D
Sarcoidosis
Looking forward to giving
@dukemedicine
Grand Rounds tomorrow.
Will review how the
#NephTwitter
community tackled a very pressing question in regards to ACE inhibitors and ARBs during the COVID-19 pandemic.
Talk will be recorded and will share it after the talk.
@MargaretD128
Excited to welcome the
@NSMCInternship
class of 2021 (the 7th)
These 35 individuals will make a big impact in medicine and nephrology
#FOAMed
#NephForward
Read out them and follow them here
ππ
IMGs comprise 49% of the nephrology workforce and 25% of the total physician workforce in the US.
@ASNKidney
continues to advocate for visa flexibility to ensure a robust health workforce. Read about our latest efforts on
@KidneyNews
:
Happy to share our latest Neph-Rheum collaboration in
@JASN_News
with my brother
@jeffsparks
#strozierproject
What?! Low dose methotrexate? ((Might)) be safe and kidney protective π€
this is exploratory analysis of RCT
very interesting study that shows the specificity of dapagliflozin for the kidney
Particularly subfigure b which shows how dapa does not bind to SGLT2 in the heart and other organs.
#Flozinate
@JASN_News
This is a very challenging year for IMGs and many others applying for residency this year. Bottom line is that there is a big maldistribution in offers for interviews this year and many are left with none or just a few offers. It truly breaks my heart to see this.
@AAMCtoday
Urging all editors of journals- take an active role in reviewing
#COVID19
research
βοΈ titles important (not time for click bait)
βοΈ ensure data not duplicated (especially from same center)
βοΈ allow for robust method section even if breaking length rules
βοΈ huge implications
Exceedingly proud of
@ssfarouk
for receiving the
@ASNKidney
Bennett Clinical Scholars Grant.
So well deserved and she will continue to make a huge impact in medicine.
#NephForward
Happy to see our guide to incorporating social media into your professional life in
@NDTsocial
This comes at a good time..in person meets will be gone for a while. Like it or not..Twitter is the hallway of professional meetings
time to join
@NatashaNDave
&
@ssfarouk
dig deep
Huge congrats to
@ssfarouk
for receiving the mid career
@ASNKidney
educator award. Well deserved recognition for her commitment and innovation in nephrology education π π
@Neph_SIM
Heading to
#KidneyWk
and feeling nervous but also very grateful to see so many amazing colleagues working to help people living with kidney disease. My first kidney week was 2003. Cannot believe almost 20 years later and we are back in person after a 2 year hiatus from a pandemic
Spironolactone reduces albuminuria dramatically. Study is only 1 year in duration but can see if trial was longer would have impressive eGFR stabilization
#NephMadness
#TeamSteroidal
Our perspective in
@CJASN
We have a lot to learn about how SARS-CoV-2 interacts with the Renin Angiotensin System (RAS)
βSound Science before Quick Judgement Regarding RAS Blockade in COVID-19β
π
π»
March
@akdhjournal
issue adds to the
#NephMadness
fun
Pleasure to work with
@niruramkumar
good fried & colleague started at
@CouncilonHTN
meetings
Advances in Kidney Physiology for the Clinician
idea was to join scientists, clinicians & visual creators
actually serious this time.
Can PubMed please make a simple filter to remove COVID-19 from searches. It is becoming impossible to find anything not contaminated.
Thank you
@HyperAHA
for selecting our paper at High Impact Paper π
βDirect Actions of Type 1 Angiotensin Receptors in Cardiomyocytes Do Not Contribute to Cardiac Hypertrophyβ
ππ
It's the last Saturday before new fellows arrive & the last Saturday of being a trainee for many amazing graduates in nephrology. Wanted to give a few of them that have meant alot to me a shutout and encouragement as the embark on the next stage. To the 2020 class
#NephForward
1/
COVID-19 has further stressed all IMGs due to the pandemic AND recent US policy that has exacerbated this group of physicians and researchers
Please share our editorial in
@MayoProceedings
where we advocate for all IMGs
@NephrodisiacMD
@javo_neyra
Very happy to see this out in
@AJPRenal
Project started during fellowship with multiple components
This particular part examines the how vascular AT1Rs control sodium excretion in the kidney to affect BP
I will never be able to understand the struggles & often overwhelming challenges my black brothers & sisters face
I sincerely promise to listen/learn, fight racism in all forms, call racism out when I see/hear it, & ensure diversity/inclusion
#BlackLivesMatter
#BlackOutTuesday
The Orlando conference center is likely the biggest contrast you can get between Remote Zoom meeting and in person conferences. The distance between rooms is impressive.
#kidneywk
Congrats to all of the winners, finalists, and submissions
Love to see innovations in education.
Congrats to entire
#ABCKidney
team. Especially
@sophia_kidney
for pushing he idea and making it happen
@ssfarouk
Hongyi Zhang and Emily Qin
Are you a med student/resident interested in nephrology!!!
Join the 2022
#NephSIM
Nephrons Program
Apps are due 11/30
π
1-year
#virtual
mentoring program with
#nephrology
learning experiences & networking opportunities
#NephForward